Quincy Bioscience Begins Recruitment for Migraine Study
Madison, Wis (Feb 9, 2012) – Quincy Bioscience is pleased to announce that recruitment is underway for a migraine study, evaluating the effectiveness of the jellyfish calcium-binding protein apoaequorin on quality of life for migraine sufferers. The Online Migraine Trial is a patient-rated outcomes study in which participants complete validated rating scales via the internet over a three month period of time. Migraineurs 18 to 50 years old who experience 3 or more migraines per month are encouraged to apply at www.onlinemigrainetrial.com. Apoaequorin is a naturally-sourced calcium-
